CMAC 2010; 12(4) | CMAC

CMAC 2010; 12(4)

Prophylaxis of nosocomial legionellosis is a currently adopted component of the general strategy to fight hospital-acquired infections. …
Clinical Microbiology and Antimicrobial Chemotherapy. 2010; 12(4):272-283
PDF

Collateral damage concept describes an adverse ecological effect associated with the use of antimicrobial agents. The main point is a …
Clinical Microbiology and Antimicrobial Chemotherapy. 2010; 12(4):284-294
PDF

Daptomycin is the first approved member of a cyclic lipopeptides class of antibiotics with anti-Gram(+) activity. In contrast to …
Clinical Microbiology and Antimicrobial Chemotherapy. 2010; 12(4):295-313
PDF

Generic drugs account for 78 to 95% of drug products on the Russian pharmaceutical market and represent a common way of decreasing …
Clinical Microbiology and Antimicrobial Chemotherapy. 2010; 12(4):314-320
PDF

Aminoglycosides is one of the main antimicrobial drug classes and continue to play a role in the treatment of several infections, …
Clinical Microbiology and Antimicrobial Chemotherapy. 2010; 12(4):321-328
PDF

Objective. To assess antimicrobial resistance and its trends among Streptococcus pneumoniae in different regions of Russia over the …
Clinical Microbiology and Antimicrobial Chemotherapy. 2010; 12(4):329-341
PDF

Objective. To investigate spectrum and antimicrobial susceptibility of colonic microorganisms isolated from biopsy samples in patients …
Clinical Microbiology and Antimicrobial Chemotherapy. 2010; 12(4):342-346
PDF

Objective. Objective: To investigate antagonistic activity of multicomponent probiotic products resulting from interactions of …
Clinical Microbiology and Antimicrobial Chemotherapy. 2010; 12(4):347-352
PDF

Clinical Microbiology and Antimicrobial Chemotherapy. 2010; 12(4):353-360
PDF